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ABSTRACT 
Colloidally prepared semiconductor nanocrystal quantum dots (QDs) are inherently 
incompatible with biological systems because of the native hydrophobic molecules that coat 
their surfaces. Post-synthetic techniques such as ligand exchange and encapsulation are 
therefore employed to make them soluble in aqueous media while preserving their valuable 
properties such as bright photoluminescence and stability. Small hydrophilic organic 
molecules like dihydrolipoic acid and tris(hydroxypropyl)phosphine are used to displace the 
hydrophobic surface ligands, and derivatization by carbodiimide bioconjugation can enhance 
pH stability. Several QD encapsulation methods in polymer shells are covered, with the most 
promising one involving the use of a four-stream vortex mixer to create QD-embedded 
polymer microspheres with a small size distribution and high fluorescence intensity. The 
ability of polyhistidine tags to self assemble onto QDs via metal coordination interactions is 
also exploited to attach dye-labeled protein molecules onto QD surfaces so as to perform 
fluorescence resonance energy transfer investigations. 
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CHAPTER 1.  
INTRODUCTION 
1.0 General Introduction 
Quantum dots (QDs) are semiconductor nanocrystals that emit electromagnetic radiation in 
the form of visible light. The optical and electronic properties of QDs are quite different from 
those of the bulk semiconductor materials; hence they have many different applications. 
Luminescent QDs are potentially very useful in biological systems, including live cell and 
tissue imaging, acting as substrates for active sensing (e.g. using FRET) and targeted 
delivery, and visualization of intracellular and protein interactions1-4. Inherently, colloidal 
QDs are incompatible with biological systems because of the native hydrophobic molecules 
that coat their surfaces, so several different post-synthetic techniques are employed to make 
them soluble in aqueous media5. These techniques need to maintain the desirable properties 
such as keeping the sizes of the particles relatively small, maintaining a high 
photoluminescence quantum yield, and ensuring broad pH stability1. Changing the outer 
layer of the QDs by exchanging the surface-coating molecules or encapsulating the whole 
nanocrystal in some sort of shell are the ways in which water solubility is achieved.  
 
1.1 Motivation/Objectives 
Water solublization of quantum dots by exchanging the surface coating has most often been 
accomplished using the hydrophilic organic molecule, dihydrolipoic acid (DHLA). However, 
the water solubility of the QDs prepared by this method depends on the ionization state of the 
carboxyl functional group, so DHLA capped quantum dots are unstable in slightly acidic 
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solutions1. For this reason, there is a need to develop alternative surface coatings that 
enhance the solution properties of the QDs. The motivation for all the ligand exchange and 
encapsulation investigations presented in the following chapters is to preserve the valuable 
properties of semiconductor nanocrystal quantum dots, while changing their solution 
properties to render them useful for biological applications by passivating their surfaces to 
keep the photoluminescence bright with surface modification that remains stable over a long 
period of time. Simultaneously, multifunctionality and pH stability are sought by combining 
organic molecules with varied functional groups on the same QD surface. 
 
1.2 Organization of Thesis 
This thesis begins in Chapter 2 with a discussion of most of the literature that is pertinent to 
understanding the nature of quantum dots and the importance of their surface modification. 
The properties that make them particularly useful to biological systems are also covered. 
The preparation of high quality, luminescent cadmium selenide (CdSe) quantum dots 
overcoated with a zinc sulfide (ZnS) shell is detailed in Chapter 3. 
Chapter 4 mainly focuses on the methods used to displace hydrophobic surface ligands using 
small hydrophilic organic molecules, some of which are derivatizable using general 
bioconjugation techniques. These new water-soluble quantum dots are capable of being used 
in various ways for biological applications. 
Encapsulating quantum dots in polymer shells is a good way to functionalize their surfaces 
and manipulate their solution properties. By embedding QDs in polymer microspheres, their 
unique optical properties such as simultaneous excitation and size-tunable emission can be 
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utilized for applications such as multiplexing6 and controlled drug delivery7-10. Several 
polymer encapsulation methods are discussed in Chapter 5. 
In fluorescence resonance energy transfer (FRET), energy is nonradiatively transferred from 
a donor to an acceptor fluorophore which are relatively close together4. Dipole-dipole 
interactions between the two fluorophores are the driving force of FRET and these 
interactions depend heavily on the distance of separation between them4, 11. FRET 
investigations between two different engineered proteins and quantum dots are covered in 
Chapter 6. 
 
1.3 References 
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Enhancing the stability and biological functionalities of quantum dots via compact 
multifunctional ligands. J Am Chem Soc 2007, 129, (45), 13987-96. 
3. Clapp, A. R.; Medintz, I. L.; Mauro, J. M.; Fisher, B. R.; Bawendi, M. G.; Mattoussi, 
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4. Clapp, A. R.; Medintz, I. L.; Mattoussi, H., Forster resonance energy transfer 
investigations using quantum-dot fluorophores. Chemphyschem 2006, 7, (1), 47-57. 
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CHAPTER 2.  
BACKGROUND AND LITERATURE REVIEW 
2.0 Introduction 
In this chapter, most of the literature that is pertinent to understanding the nature of quantum 
dots and the importance of their surface modification is discussed. Section 2.1 gives a general 
overview of the quantum mechanical concepts that explain the confinement effects 
experienced by semiconductor nanocrystals. Section 2.2 summarizes the quantum dot 
properties that make them important in biological applications. The most commonly used 
synthesis and shell overcoating methods are described in Section 2.3 as well as some of the 
organic molecules used as coordinating solvents for synthesis. Some alternative synthetic 
routes are discussed in Section 2.4. Water solublization techniques that enable biological use 
of quantum dots are detailed in Section 2.5 and some biological applications are outlined in 
Section 2.6. 
 
2.1 Band Gaps and Quantum Confinement 
A band gap/electronic energy level spacing (Eg) is the region where electron energy levels 
cannot exist. In semiconductors, it is the energy difference/interval between the top of the 
valence band (Ev) and the bottom of the conduction band (Ec).  
E  E  E 
If Eg is less than 3 or 4 eV, the conduction band has a non-negligible population at higher 
temperatures, and this type of crystal is called a semiconductor. Electrons are confined to the 
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energy bands but are able to jump from one to another using a specific amount of energy, 
which differs according to the material type1. 
 
Table 2-1: Important constants for common semiconductors1, 2 
Bulk 
Semiconductor 
Band Gap Energy - Eg 
(eV) 
Exciton Bohr Radius - aB 
(nm) 
Lattice Constant - aL 
(nm) 
Ge 0.744  0.565 
Si 1.17 4.3 0.543 
GaAs 1.518 12.5 0.565 
CdTe 1.60  0.648 
CdSe 1.84 4.9 0.605 
CdS 2.583 2.8 0.583 
ZnSe 2.820 3.8  
AgBr 2.684 4.2  
CuBr 3.077 1.2  
CuCl 3.395 0.7  
ZnS 3.6  0.542 
 
In bulk semiconductor crystals, the band gap has an average fixed value as illustrated in 
Table 2-1, and  the wavelength associated with (i.e. the de Broglie wavelength of) an electron 
(λe), a hole (λh), and the exciton Bohr radius (aB) can be much larger than the lattice constant 
(aL) of the crystal. Therefore, the size of a nanocrystal can be equal to or less than λe, λh, and 
aB, but larger than aL. It is thus possible to fabricate low-dimensional structures with sizes 
restricted to a few nanometers. In these nanocrystals, the band gap depends on the size of the 
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crystal, and can be altered to produce a series of energies that lie between the conduction and 
the valence band of the material1, 3.  
Semiconductor nanocrystals have been described as quantum dots, nanoparticles, or 
nanoclusters4, 5. These nanocrystals are clusters of semiconductor molecules that are 
structurally identical to the bulk material. They can be made from group II-VI 
semiconductors (e.g. CdS, CdSe, CdTe, ZnSe), group III-V semiconductors (e.g. InP, GaAs, 
InAs) and group IV-VI semiconductors (e.g. CuCl, CuBr), among others5. The band gaps of 
nanocrystals increase as the size of the material decreases6. The size of the nanocrystals also 
directly affects electrical transport because of the differences in energy needed to add charges 
or remove them5. 
The band gap energy is the minimum amount of energy needed to create one free electron-
hole pair or an exciton, which is a quasiparticle formed by the Coulomb potential interactions 
between electrons and holes. A semiconductor crystal transitions from the ground to the first 
excited state when a photon is absorbed, with an electron being stimulated to cross the band 
gap into the conduction band and leave a hole in the valence band. For this to occur, the 
energy of the photon has to be greater than or equal to the band gap energy of the crystal. The 
energy and momentum of the photon are conserved, so, as the electron falls back down to the 
valence band, the crystal ideally emits radiation in the form of visible light1. 
To understand the absorption and emission of light in nanocrystals, consider the quantum 
confinement approach in which a nanocrystal is considered to be a three-dimensional box. If 
a photon is absorbed or emitted, elementary excitations are created or destroyed. These 
elementary excitations can be electrons, holes, or excitons and will experience quantum 
confinement resulting in finite motion along the confinement axis and infinite motion in 
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other directions. If the size is restricted in only one dimension, a two-dimensional structure 
called a quantum well results. If two-dimensional quantum confinement occurs, a one-
dimensional structure called a quantum wire results. If the motion of the electrons, holes, and 
excitons is restricted in all three dimensions, a quasi-zero-dimensional system called a 
quantum dot results. Thus quantum dots are in a state of complete quantum confinement1. 
The exciton Bohr radius is the physical separation between an electron in the conduction 
band and a hole in the valence band, which varies depending on the material being 
considered. In a bulk semiconductor, this radius is small compared to the size of the 
semiconductor so the exciton is free to move around in the material. Since the size of a 
quantum dot is on the order of the exciton Bohr radius, the exciton becomes confined in the 
“box”, so the electronic energy levels can be treated as discrete instead of continuous as seen 
in bulk semiconductor materials. 
The energy levels in the bulk are separated by very small amounts of energy so they are 
assumed to be continuous. Due to the small size of quantum dots, the addition or removal of 
just one atom changes the energy of the band gap noticeably, because the energy levels are 
separated by larger amounts of energy than in the bulk. One of the physical effects of 
quantum confinement is the shift of electronic excitations to higher energies as the size of the 
particle is reduced so depending on the number of atoms present, a specific wavelength of 
radiation is emitted when the electron drops back into the valence band, making quantum dot 
band gaps size tunable5. 
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2.2 Properties of Quantum Dots 
Quantum dot nanocrystals are clusters of atoms with an interior that is indistinguishable 
structurally from the bulk solid, but the majority of the total number of atoms are on the 
surface of the cluster5. The surface therefore plays an important role in the properties of the 
crystal. 
The properties of semiconductor quantum dots make them very useful biologically for optical 
imaging and labeling7. Some of these properties include high quantum yields, brightness, 
narrow emission spectra, large molar extinction coefficients, photostability, and the ability of 
the band gaps to be tuned over most of the visible spectrum wavelengths8-12. This band gap 
tunability arises because the positions of the initial absorption peaks can be shifted over a big 
portion of the band gap of the bulk material5.  
 
 
Figure 2-1: Quantum dot absorption spectrum showing absorption onset at 510 nm 
 
What is most observable about quantum dots is the large change in their optical properties 
with respect to cluster size, since this directly influences the optical excitations across the 
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gap. This occurs in clusters even as large as 10000 atoms, but not in the bulk material5. By 
reducing the diameter of the semiconductor cluster of CdSe, for example, from 20 to 2 nm, 
the band gap can be tuned from deep red at 1.7 eV to green at 2.4 eV13. The absorption 
spectra of quantum dots exhibit a succession of overlapping peaks that decrease in size as the 
wavelength increases. Each of the peaks corresponds to an energy transition between the 
aforementioned discrete electronic energy levels. The peak with the largest wavelength 
serves as the absorption limit of the quantum dot, also known as the absorption onset. The 
position of the absorption onset peak depends on the type and size of the semiconductor 
nanocrystal being considered. For smaller quantum dots, the first peak occurs at shorter 
wavelengths. The broad absorption spectra enable quantum dots to be excited over a wide 
range of wavelengths, whilst producing a narrow emission profile. 
 
 
Figure 2-2: Quantum dot emission spectrum with narrow size distribution and peak at 560 nm 
 
The emission spectra of quantum dots demonstrate a Gaussian (bell-shaped) distribution with 
the peak at a wavelength slightly higher than the absorption onset peak of the absorption 
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spectra. The separation between the absorption and emission peaks is called the Stokes shift 
and is quite large for quantum dots. This is especially valuable in applications involving 
multiplexing because several different QD samples can be excited at the same time with a 
single wavelength distant from the emission wavelengths of any of the samples10, 14, 15. The 
size distribution of the quantum dot sample determines the width of the emission curve with 
a narrower curve indicating that the size distribution is smaller. A smaller distribution is 
more favorable and can be achieved by growing or size-selecting monodisperse nanocrystals 
(nearly identical in size and shape). 
 
2.3 Colloidal Quantum Dots  
2.3.1 Crystalline Core Synthesis 
The crystalline core of colloidal quantum dots can contain about 100 to 10000 atoms of the 
semiconductor material5 and can range in diameter from about 1 to 20 nm16. Successful 
synthesis should produce highly crystalline nanocrystals, a monodisperse size distribution, 
the ability to vary the size and shape, and control over the optical and other properties3. In 
order to accomplish this, the crystallization process must be strictly controlled by forming a 
supersaturated solution at about 250 to 360°C in which nucleation occurs and subsequent 
crystal growth over the initial nuclei4, 17. For monodisperse crystals to result, the nucleation 
period needs to be very short18. 
Up until the year 2000, the best synthesis was an organometallic approach using Cd(CH3)2 
(dimethyl cadmium) in technical grade trioctylphosphine oxide (TOPO) as a coordinating 
solvent with other additives13, 19-22. Selenium metal was combined with an organophosphine 
compound such as trioctylphosphine or tributylphosphine before being used for synthesis. 
12 
 
The disadvantages of this approach included the fact that some of the raw materials and 
precursors were extremely toxic, expensive, unstable, explosive, and even pyrophoric so 
expensive equipment with an inert atmosphere (such as a glove box) was required. The 
reactions were also difficult to control and reproduce and other types of semiconductor 
nanocrystals of comparable quality to CdSe had not been produced by this approach3, 17. 
The need for a shift towards somewhat safer and less expensive raw materials as well as 
simpler equipment and procedures was felt. Different cadmium precursors were used, 
including inorganic and organic cadmium salts (e.g. cadmium carbonate, cadmium acetate)3. 
The newer synthetic routes were able to produce nanocrystals in a broad range sizes from 1.5 
to 25 nm17 that were nearly monodisperse since 5 to 10% relative standard deviation was 
achievable. A photoluminescence (PL) quantum efficiency of up to 85% was also reached23. 
Other semiconductor nanocrystals such as CdTe and CdS were also produced by these safer 
routes12. 
During synthesis, a 100% conversion of raw materials to nanocrystals is impossible since 
some excess precursors (e.g. cadmium molecular species) and monomers must exist in the 
growth solution to suppress Ostwald and intraparticle ripening during the crystal growth 
process19, 24. To induce the supersaturation required to form quantum dots, the organometallic 
precursors are injected swiftly into a flask holding the vigorously stirring coordinating 
solvents at a high temperature4. The synthesis of cadmium selenide (CdSe) quantum dots has 
been developed most and several sources of Cd have been used including dimethyl cadmium 
(Cd(CH3)2)4, cadmium oxide (CdO)12, and cadmium acetylacetonate (Cd(acac)2)14, 17. 
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2.3.2 Organic Coordinating Ligands 
To prevent colloidal nanocrystals from aggregating and to make them soluble, their surfaces 
are derivatized with organic molecules16. Derivatization is a reaction used to transform a 
material into a derivative which has a similar chemical structure but new chemical properties. 
The organic molecules are attached to the quantum dot surface by metal coordination 
interactions and provide passivation, thus making them soluble without aggregation. It has 
been suggested that they do not provide good electronic passivation so the use of inorganic 
molecules instead has been proposed5. 
Some molecules used as ligands include thiols, fatty acids, amines, phosphonic acids, 
phosphine oxides, nitriles, phosphines, and carboxylic acids3. By carefully selecting the 
functional groups appended to the quantum dots it is possible to control the types of 
environments they can disperse in. The most commonly used ligands are trioctylphosphine 
(TOP) and trioctylphosphine oxide (TOPO).  The use of hexadecylamine (HDA) as a 
passivating ligand in addition to TOP/TOPO has been shown to provide better control over 
the growth dynamics of quantum dots and to produce very monodisperse samples as well25. 
As discussed previously in the case using dimethyl cadmium (Cd(CH3)2) as a precursor, 
metallic Cd precipitated immediately out of pure TOPO at high temperatures. Adding an 
equal or greater molar amount of hexylphosphonic acid (HPA) was found to stabilize the 
(Cd(CH3)2). This is because a soluble Cd-HPA complex was formed, resulting in a clear 
solution19. This same complex was also formed when CdO was introduced into a high 
temperature mixture of HPA and TOPO. The addition of a selenium-organophosphine 
solution (e.g. TOP/Se) into the Cd-HPA complex solution was shown to produce high quality 
 
 Table 2-2: Common organic molecules used as coordinating solvents for quantum dot synthesis
Organic Molecule
Trioctylphosphine (TOP)
Trioctylphosphine oxide (TOPO)
 
Hexadecylamine (HDA)
 
Hexylphosphonic acid (HPA)
 
nanocrystals 2 nm or smaller in size, but larger ones 
method3, 17. 
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 Structure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
were difficult to produce using this 
 
 
 
 2.3.3 Shell Overcoating
The positions of the atoms at the surfaces of tetrahedral inorganic semiconductors become 
greatly restructured, resulting in surface states, which are energy levels that are within the 
forbidden gap of the bulk solid. Electrons and holes get t
degrading the material’s optical and electrical properties. Nonradiative recombination can 
also occur where an electron recombines with a hole but the energy generated is released in 
the form of heat instead of light. To 
recombination from occurring, a chemical process that bonds the surface atoms of the 
 
Figure 2-3: Schematic representation 
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rapped in this forbidden gap, thus 
prevent these surface states and nonradiative 
of a layer of TOPO molecules on the outer surface of a quantum dot
 
 
26
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crystalline core to another material with a much larger band gap is carried out. This process, 
termed passivation, eradicates the surface states that are within the forbidden gap and instead 
produces an increase in the chemical potential. Since particles move from regions of high 
chemical potential to lower ones, the electrons and holes at the interface of the two materials 
become confined within the semiconductor cluster because the passivating material has a 
higher chemical potential5. 
Several layers of atoms of a wider band gap semiconductor are required to successfully 
overcoat the core of the quantum dot. Emission becomes brighter because of the absence of 
the surface states and nonradiative recombination. Overcoating also makes the quantum dot 
more robust and able to endure harsher conditions. The quantum yield of a quantum dot is 
the percentage of photons absorbed that result in photons emitted, so better overcoating 
results in a higher quantum yield8.  
For CdSe quantum dots, the most common materials used for overcoating include ZnS8, 
CdS24, and ZnSe27. During the overcoating process, the precursors are added very slowly to 
the coordinating solvents and quantum dots to ensure uniform growth over the surface of the 
QDs. 
 
2.4 Alternative Synthetic Routes 
Solvents such as fatty acids, amines (e.g. dodecylamine), and phosphonic acids (e.g. 
tetradecyl phosphonic acid – TDPA), have been used as coordinating solvents for quantum 
dot synthesis, most often in conjunction with TOPO17. Some syntheses of CdSe in 
water/aqueous solutions have also been described using inorganic cadmium salts.  Some of 
the syntheses use L-cysteine in the reaction mixture to cap the quantum dots. The quality of  
 Table 2-3: Alternative coordinating solvents used for quantum d
Organic Molecule
 
Dodecylamine (DDA) 
 
 
Tetradecylphosphonic acid (TDPA)
 
Cysteine 
1-Octadecene 
Oleic Acid 
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the nanocrystals produced is poor presumably because high temperatures cause better 
crystallinity and the reaction temperature for aqueous synthesis cannot be raised to 200 – 
360°C as in the organometallic approach3, 28, 29. 
Sapra et al.30 describe a method of quantum dot synthesis that utilizes olive oil as a 
coordinating solvent instead of TOP/TOPO. The crystals produced ranged in size from 2.3 to 
6.0 nm and emit radiation over the range 485 to 640 nm. Synthesis using non-coordinating 
solvents such as 1-octadecene (ODE) has also been reported. Oleic acid was used as a ligand 
to stabilize the precursors and nanocrystals and was found to influence the growth kinetics 
depending on its concentration. CdS, ZnSe, and CdSe were successfully synthesized using 
this method. The CdSe nanocrystals ranged in size from 1.5 to 20 nm31. 
 
2.5 Water Solublization 
After most synthetic procedures, the nanocrystals used are covered in hydrophobic surface 
ligands. For biological applications, the quantum dots need to be water soluble. The nature of 
the surface ligands determines the types of solutions the nanocrystal will be stable in; 
therefore the ease of derivatization is very important. Concurrently, the nanocrystal’s small 
size, pH stability, and high quantum yield must be preserved7. Water solublization can be 
achieved by either encapsulating the nanocrystal in some hydrophilic material or exchanging 
the hydrophobic ligands with hydrophilic ones. 
 
2.5.1 Encapsulation 
To produce a hydrophilic surface, the quantum dots may be encapsulated in amphiphilic 
polymers, silica shells, micelles, or phospholipids32-39. Although these encapsulated quantum 
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dots have high quantum yields, their diameters are greatly increased by the polymer shells. 
This can make the nanocrystals larger than some of the sub-cellular structures being labeled, 
and hinder their movement through the cell. The diameter has been observed by Smith et al.40 
to increase from about 4 – 6 nm (for non-encapsulated quantum dots) to 20 – 30 nm. Polymer 
shells also tend to possess an electrostatic charge and so add to non-specific binding of the 
nanocrystals to cell membranes7. 
 
2.5.2 Ligand Exchange 
To reduce the diameters of water soluble quantum dots, the native hydrophobic ligands can 
be displaced by small organic molecules that are able to bind to the ZnS shell. Some 
examples of ligands used for exchange include dihydrolipoic acid (DHLA), PEG-appended 
DHLA11, 41, 42, thiol-alkyl-COOH, amine-alkyl-COOH9, cysteine ligands43, and 
phytochelatin-related R-peptides44. 
Dihydrolipoic acid (DHLA) is a carboxylic acid that contains a pair of thiols that are able to 
bind to the quantum dot surface. It has been used in place of monothiol molecules such as 
mercaptoacetic acid because of the enhanced stability and stronger interaction to the quantum 
dot surface provided by the two sulfur atoms11, 45, 46. DHLA-capped quantum dots, however, 
are unstable in acidic conditions, not easily derivatizable, and bind non-specifically to cells7, 
11
 so modifications to DHLA by appending various lengths of poly(ethylene glycol) (PEG) 
using ester bonds have been done. Quantum dots possessing these DHLA-PEG ligands are 
very water soluble and therefore useful for biological applications.  
 
 
 Table 
Ligand 
Dihydrolipoic Acid
 
PEG-appended DHLA
 
 
Histidine 
 
 
Unfortunately, just like DHLA, these ligands provide only a hydroxyl group, so further 
derivatization is difficult and the ester bond between the DHLA and PEG groups is easily 
hydrolysable7, 41, 47. They also cause a large increase in the size of the quantum dots.
Stable aqueous solutions of quantum dots have been formed using peptides containing 
cysteine residues but the size of the quantum dots becomes 
nm) because of the large size of the peptides
using polyhistidine-tags (His
20 
2-4: Common molecules used in cap exchange 
Structure 
 (DHLA) 
 
 
 
 
 
 
 
 
quite large (approximately 15 
44
. Metal-affinity interactions are also employed 
-tags) engineered onto biomolecules which are able to self
 
 
 
-
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assemble onto quantum dots through interactions between the His-tag and metal ions on the 
nanocrystal surface35, 48. This process provides control over the quantum dot to protein ratio. 
It is also possible to covalently modify the nanocrystal surface using carbodiimide 
bioconjugation techniques such as amide coupling reactions between amino and carboxyl 
groups42. 
 
2.6 Biological Applications of Quantum Dots 
Compared to traditional dyes and fluorescent proteins, quantum dots are much more useful 
for imaging cells at a molecular level because of their advanced photostability and 
brightness49. They have been used in biological systems as probes and sensors that are much 
more robust and stable than dyes. Their broad absorption and narrow emission spectra also 
make quantum dots ideal for multiplexing applications. This is because several different 
nanocrystals can be excited at the same wavelength but will emit different colors10, 15. 
Relative to organic dyes, the larger size of quantum dots enables them to act as platforms for 
attaching different molecules and thus providing diverse functionality. An example of the use 
of quantum dots in vivo is the study done by Stroh et al.50 in which the nanocrystals were 
used to differentiate between cancerous tumor cells and host cells in transgenic mice. 
 
2.6.1 Fluorescence Resonance Energy Transfer (FRET) 
Fluorescence resonance energy transfer (FRET) is a mechanism by which energy is 
transferred from a fluorescent donor molecule to a fluorescent acceptor molecule51. The 
transfer is driven by dipole-dipole interactions and is highly dependent on the distance 
between the two molecules, which makes it useful for monitoring biological phenomena52-54. 
 FRET has been shown to occur between quantum dots and organic dyes attached to proteins 
with an increase in the FRET signal as the number of proteins attached to the nanocrystal is 
increased52. 
 
2-4: Schematic representation 
 
Due to its distance-dependent nature, FRET is a useful method for measuring distances in the 
angstrom to nanometer range. This is very helpful for applications such as deri
structure of complex molecules like proteins by measuring the distances between amino 
acids. FRET is also valuable for detecting enzymatic activity. After a dye
been attached to a quantum dot, FRET occurs between the nanocrysta
emission of the nanocrystal becomes quenched. The emission increases again only after the 
peptide has been cleaved by the enzyme
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-labeled peptide has 
l and the dye, so the 
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CHAPTER 3.  
QUANTUM DOT SYNTHESIS  
3.0 Introduction 
The preparation of high quality, luminescent cadmium selenide (CdSe) quantum dots is 
described in this chapter following general procedures previously described1-5. The size of 
these nanocrystals is relatively easy to control  and by capping CdSe with the higher band 
gap semiconductor material with similar lattice constants, ZnS,  greater stability and 
improved luminescence is realized4, 5. 
Precursors were reacted in coordinating solvents at high temperatures to produce crystalline 
cores (Sections 3.1 – 3.3), which were overcoated with a thin layer of ZnS to produce very 
luminescent CdSe-ZnS core-shell quantum dots (Section 3.4). Purification and size selection 
methods of the QDs are described in Section 3.5 and the nanocrystals are characterized by 
various methods in Section 3.6. 
 
3.1 Apparatus and Experimental Setup 
A relatively simple setup was required for quantum dot synthesis (Figure 3-1). The reaction 
was carried out in a three/four-neck Erlenmeyer bulb (round-bottom flask) connected by one 
neck and a condenser to a dual manifold inert/vacuum Schlenk line. Nitrogen (N2) was used 
as the inert gas with a pressure of 2-4 psi, and a positive displacement rotary vane vacuum 
pump was usually able to pull a vacuum of about 10 Pa. Another neck allowed a 
thermocouple temperature sensor, encased in a glass rod and connected to a heating mantle, 
to read the temperature of the solution. The third and fourth necks were covered with septum 
 stoppers and tightly secured, enabling solutions to be
reaction was proceeding. 
 
Figure 3-1: Schematic representation of quantum dot synthesis apparatus setup
 
An inert atmosphere glove box (MBRAUN Unilab) with a cooler 
air-sensitive materials. 
 
3.2 Coordinating Solvents and Precursors
Modifying procedures previously outlined 
covered with glass wool to retain heat,
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 injected into the air-free flask when a 
was used to handle all the 
 
1-3, 6
, a 100 mL three-neck Erlenmeyer bulb, 
 was filled with 20 g trioctylphosphine oxide (TOPO),
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10 g hexadecylamine (HDA), and 5 mL of 90 or 97% tech. grade trioctylphosphine (TOP). 
The bulb was heated to 125 – 140°C for 1 – 2 hours under vacuum to dry and degas the 
coordinating solvents. A coordinating solvent mixture of TOP/TOPO/HDA has been found to 
narrow the size distribution of CdSe nanocrystals during synthesis, eliminating the need for 
extensive post-synthetic size selection6. 
 The ratio of TOPO to HDA was varied occasionally7 and TOP was no longer used in the 
reaction vessel but added to the cadmium precursor instead. A 1:1 molar ratio of TOPO to 
HDA changed the starting amounts to 19.2 g TOPO and 12 g HDA. HDA seemed to play a 
role in the QD sizes produced, so in attempts to synthesize smaller (bluer) quantum dots, 
only 16 g TOPO was used with 14 g HDA and 4 – 5 mL TOP was again added. The amount 
of HDA was gradually increased, with 15 g each of TOPO and HDA used until finally, 12 g 
TOPO and 18 g HDA with 5 mL TOP was found to produce the smallest QDs. 
 
3.2.1 Cadmium Precursors 
Previously described procedures were used to prepare the cadmium precursors1. For most 
syntheses the organometallic cadmium acetylacetonate [Cd(CH3COCHCOCH3)2 • xH2O] – 
(Cd(acac)2) was used. Generally, 0.62 g of Cd(acac)2, 1.2 g of 1,2-hexadecanediol (HDDO), 
and 10 mL of 90 or 97% TOP were heated to 100 – 110°C in a scintillation vial in an oil 
bath. The system was evacuated and refilled with N2 gas a few times then placed under 
vacuum. Just before being injected into the coordinating solvent solution, the environment 
was switched to N2 gas and cooled to 80°C. 
To cover the visible spectrum, a range of 0.25 – 3.0 mmol Cd(acac)2 has been suggested7 
with solvent amounts remaining the same. Therefore, only the ratios of Cd to HDDO and Se 
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needed to remain constant at 1:2.3:5. So 0.155 g Cd(acac)2, 0.3 g HDDO, and 10 mL TOP 
were used with 2.5 mL TOP:Se (1M stock solution) for synthesis. 
When attempting to make smaller quantum dots, 0.8 g of hexylphosphonic acid (HPA) or 1.4 
g of tetradecylphosphonic acid (TDPA) was added to 0.62 g Cd(acac)2 and 10 mL TOP, and 
then heated to 100 – 110°C. HPA and TDPA were able to convert the cadmium precursor 
into a Cd/HPA or Cd/TDPA complex when the cadmium to phosphonic acid ratio was lower 
than one, and addition of the selenium precursor generated high quality, small nanocrystals2. 
Besides Cd(acac)2, cadmium oxide (CdO) has also been shown to produce monodisperse 
CdSe nanocrystals with phosphonic acids because its instability in relation to these acids 
causes the Cd/acid complex to form readily2. The use of dodecylamine (DDA) for synthesis 
of CdTe nanocrystals was previously described8, so a CdSe synthesis was carried out using 
0.13 g CdO, 0.78 g TDPA, 7.4 g DDA, and 5.14 g TOPO. The solution began to boil at 
274°C since DDA has a boiling point of 247 – 249°C. Therefore the synthesis was carried 
out with 9 g of HDA instead and heated to 140°C. Before addition of the selenium precursor, 
the temperature was raised to 280°C, and at 240°C the solution became clear. 
 
3.2.2 Selenium Precursor 
According to the procedure described by Murray et al.3, a 1M stock solution of 
trioctylphosphine selenide (TOP:Se) was prepared inside the MBRAUN Unilab glove box by 
dissolving 7.9 g of Se powder  in 100 mL of 90 or 97% TOP. For QD synthesis, 10 mL of the 
solution was removed from the glove box with a syringe. Selenium shot was originally finely 
ground by a mortar and pestle before use to ensure smooth and rapid injection into the 
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coordinating solvent solution, but we found that using 99.5% selenium powder was just as, if 
not more, effective. 
 
3.3 Synthesis 
Before the reaction commenced, the cadmium and selenium precursors were drawn up into 
syringes. It was important to do this only right before injection into the coordinating solvents 
because of the tendency of the cadmium precursor to solidify when its temperature dropped 
below 80°C. The Erlenmeyer bulb containing the coordinating solvents was switched to a 
nitrogen atmosphere and the temperature was raised to 250 – 350°C depending on the size of 
nanocrystals desired. The temperature control was always set slightly high so that the flask 
did not fall too far below the desired injection temperature when the heating mantle was 
removed. The set point was raised in small increments because of the tendency of the 
thermocouple to overshoot if the range was too wide. 
Before injection, the heating mantle was quickly removed from the coordinating solvent flask 
and the precursors were rapidly injected in. If injection is not instantaneous, different sized 
nanocrystals will be formed. A visible color change from clear to deep orange/ brown 
indicated immediate reaction between the precursors. The flask was rapidly cooled to below 
200°C using ethanol sprayed directly onto flask and the cool setting of a heat gun. The 
thermostat was set to 80°C because the nanocrystals grew and their emission increased by 
about 10 nm even at 150°C. The heating mantle was replaced, and the solution left to stir for 
a few hours or overnight. To remove any unreacted metal salts or impurities in the solution, 
toluene, butanol, and hexane were added and the solution was centrifuged. The impurities 
remained on the bottom of the vials. The nanocrystals were then purified.  
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When attempting to make smaller nanocrystals, the Cd precursor mixture was injected into 
the coordinating solvents immediately after they were degassed, but the TOP:Se was added 
after raising the temperature. The reaction proceeded very slowly so quenching it faster 
resulted in smaller nanocrystals. It was found that even after the reaction had been quenched, 
the nanocrystals continued to grow at 80°C. We postulated that injection temperatures around 
250°C possibly did not enable all the Cd and Se to react, so the size increased over time 
because of the large amount of unreacted precursors remaining in the solution. Therefore, for 
smaller nanocrystals, leaving the flask at 80°C for several hours is undesirable because the 
QDs tend to grow larger. Purification should be done immediately after synthesis. 
 
 
Figure 3-2: Growth curve of the peak absorption and emission wavelengths of CdSe nanocrystals over time 
 
When larger nanocrystals were desired, the flask was not cooled below 200°C after injection, 
but left at the injection temperature over a period of time. Every five to ten minutes, the 
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fluorescence spectra of samples taken from the flask were obtained. The growth curve was 
steep over the first few minutes but began to level off over time, indicating the maximum QD 
size had been reached (Figure 3-2). 
A phosphine-free synthesis was carried out using olive oil as the coordinating solvent 
according to a procedure described by Sapra et al. In this method, cadmium oxide (CdO) is 
stabilized by oleic acid (OA)9, 10 which is found naturally at about 70 – 80% in olive oil11. 
Oleic acid is also able to dissolve selenium at higher temperatures9. 
40 mL of extra virgin olive oil was used to dissolve 0.103 g CdO under N2 gas at 300°C. 
0.032 g Se was dissolved in 8 mL of oil at 200°C under N2 gas for 2 – 3 hours, and then 
cooled to room temperature. The Se solution was injected swiftly into the hot Cd solution at 
230 – 300°C. The crystals could be grown further at 220 – 280°C depending on the injection 
temperature. Highly luminescent red QDs resulted with emissions ranging from 638 to 650 
nm, but their crystal structure was cubic zinc-blende instead of the hexagonal wurtzite 
structure typical of organometallic syntheses of CdSe QDs9. 
 
3.4 Zinc Sulfide Shell Overcoating 
The precursors used to create a zinc sulfide shell over the surface of CdSe nanocrystals are 
diethyl zinc (ZnEt2), which is pyrophoric, and hexamethyldisilathiane (TMS2S), which 
possesses a strong sulfur smell. Therefore, both precursors require an inert atmosphere (glove 
box) to be used. The procedure outlined by Clapp et al.1 was followed. 
In a 100 mL Erlenmeyer bulb fitted with a pressure-equalizing addition funnel, 12 – 30 g of 
TOPO was melted under N2 gas at 70°C. In a few instances, 3 – 4 mL of TOP was added as 
well. In others, 8 – 10 g of HDA was added to a batch of QDs and 16 – 40g TOPO and 
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degassed at 140°C for 3 hours. It appeared as though HDA caused the QDs to stick to the 
uncoordinated ligand molecules during purification, so HDA was no longer used for 
overcoating. The system was switched from the N2 atmosphere to vacuum and degassed for 2 
– 3 hours to remove water and air, a purified QD solution was added, and the toluene 
evaporated. To prevent letting air into the solution when adding QDs, in one system, the QDs 
were first dried by evaporating toluene off, then TOPO and TOP were added and degassed. 
Raising the temperature far above 70°C (e.g. 128°C) before adding the purified QD solution 
caused the toluene to boil violently due to the low pressure and elevated temperature. TOPO 
was pushed up into the Schlenk line where it solidified and clogged the glass tubing. After all 
the toluene boiled off, the system was switched back to N2 and the temperature was raised to 
140 – 180°C depending on the initial core radius. If the temperature is too high, the size 
distribution of the QD sample broadens1. 
To a scintillation vial containing 5 mL TOP in the glove box, equimolar amounts of ZnEt2 
and TMS2S were added, corresponding to the number of overcoating layers required for the 
particular core radius being used (usually 5 or 6 layers). The solution was loaded into a 
syringe inside the glove box and transferred quickly into the addition funnel to avoid 
exposure to air. Slowly, the solution was added into the TOPO/QD mixture at a rate of about 
½ drop per second. The temperature was lowered to 80°C and the solution stirred overnight, 
which improved the quality of the shell. 
Qu et al. describe a procedure in which the synthesis and overcoating take place successively 
without a purification step between them12. In one process, the Cd and Se precursors were 
injected into coordinating solvents at 325°C and after 1 ½ hour, the Zn and S precursors were 
added as well. In another process, butanol was added to the newly synthesized QDs without 
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purification and set aside. 20g TOPO was degassed and the QD/butanol solution was added 
at 70°C. The overcoating precursors were then added, but by the next day, the TOPO had 
solidified. The final one-step synthesis/overcoating involved using 10 g HDA with 30 g 
TOPO and degassing at 140°C for 2 hours, before adding unpurified QDs in butanol. The 
butanol was evaporated at 60 – 70°C and the temperature was raised before addition of the 
Zn and S precursors. 
 
3.5 Purification and Size Selection 
The temperature of the solution was kept above 60°C before being diluted to prevent TOPO 
from solidifying. Dilution with equal volumes (about 4 mL each) of toluene, butanol, and 
hexane was found to be best to prevent solidification. When hexane was used alone, the 
solution solidified, probably forming irreversible aggregates. Placing the vials in the 
refrigerator also caused solidification and aggregation. When butanol was used alone, 
aggregation seemed to occur, but at a slower rate than with hexane. Using too much solvent 
on the other hand made the solution overly dilute, so QDs could not be recovered from 
solution. 
The QD/solvent solution was poured into several 20 mL scintillation vials (with each having 
about 5 mL) and methanol was added until the QDs began to precipitate. If precipitation did 
not occur, each solution was split into more portions since they may be too concentrated. The 
vials were centrifuged at 3500 rpm for 10 minutes and the QDs dropped out of solution. The 
solvents were decanted and discarded. The QDs were dried by spreading around carefully on 
the bottom of each vial using a spatula, placing the vials uncovered at the back of a fume 
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hood, and leaving them to dry by evaporation of the methanol. They were then resuspended 
in a small volume of toluene using a sonic bath. 
On the rare occasion that a monodisperse sample was not produced, size-selection was 
carried out. When the QDs were freshly synthesized, the solution was diluted with butanol, 
divided into 5 mL portions in scintillation vials and topped off with butanol and about 30 
drops of methanol. Centrifugation resulted in two sizes of QDs emerging – larger ones 
dropped out of solution and smaller ones remained suspended. The solution was decanted, 
divided into 5 mL portions again and 10 mL methanol added. The QDs remaining in the first 
vials were resuspended in toluene and the second vials were centrifuged to drop the 
remainder of the QDs out. 
 
3.6 Characterization 
A handheld ultraviolet fluorescent lamp (UV lamp) is used to initially check the color of QDs 
after synthesis and overcoating (Figure 3-3). This gives a general indication of the size and 
emission wavelength of nanocrystals produced (Table 3-1). 
A Varian Cary 50 Bio Ultraviolet-visible (UV/Vis) spectrophotometer was used to measure 
the absorption profile of each QD sample. Briefly, the same solvent used to dissolve the QD 
sample was used to create a blank in a plastic cuvette. About 3 – 5 drops of QD solution was 
added to the blank and mixed with a pipette. The spectrophotometer was used to collect the 
spectrum. 
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Figure 3-3: Different sized QD samples emitting fluorescence while being illuminated by a UV-lamp 
 
An Horiba Jobin Yvon Fluoromax®-4 spectrofluorometer was used to measure the emission 
profile of each QD sample. A cuvette with a very dilute sample of QD solution (such that the 
color of the solution was barely visible in normal light) was prepared. The fluorescence 
spectra were obtained using an excitation wavelength of 350 nm and 2 nm as the 
monochromator slit width. The literature values for the fluorescence wavelengths emitted by 
QDs relative to size are given in Table 3-1.  
 
Table 3-1: Approximate breakdown of sizes, colors and emission wavelengths of quantum dots13, 14 
Size (nm) Color Emission Wavelength (nm) 
2 Blue 450-495 
3 Green 495-570 
4 Yellow 570-590 
5 Orange 590-620 
6 Red 620-750 
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Figure 3-4 contains the absorption and emission data for a population of thirty QD samples 
prepared with the methods described in Sections 3.2 to 3.5. The average absorption and 
emission peak wavelengths are plotted against the fluorescence color observed using a 
handheld UV lamp. These results closely follow the colors and wavelengths predicted in the 
literature13, 14 as evidenced in Table 3-1. The difference between the absorption and emission 
peak wavelengths is the Stokes shift which averaged approximately 25 nm over the thirty 
sample population. 
 
 
Figure 3-4: Average absorption, emission peak wavelengths, and fluorescence colors of thirty QD samples 
 
The crystallinity of the QDs was determined using transmission electron microscopy (TEM) 
of CdSe/ZnS core/shell nanocrystals at the Ames Laboratory at Iowa State University. A 
2007 JEOL 2100 200 kV scanning and transmission electron microscope (STEM) was used. 
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Supplementary TEM images can be 
 
Figure 3-5: TEM image and electron diffraction pattern of colloidally prepared CdSe/ZnS core
The photoluminescence (PL) quantum yield (QY) is basically a measure 
brightness of a QD sample15, however it is not stable 
by passivation of the core through overcoating and surface ligands. To measure the PL QY of 
a sample, an organic dye with an emission spectrum that overlaps that of the QD sample 
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il very dilute and much less dense coverage of 
. Lattice fringes, an approximately monodisperse size 
6 nm) were observed (Figure 3
found in Appendix I.  
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considerably was chosen as a standard, in this case fluorescein. A quartz cuvette was filled 
with 1M sodium hydroxide solution (NaOH) and 1 – 2 drops of fluorescein was added (just 
enough to see a visible color). The absorption spectra of both the fluorescein and QD samples 
were taken. An absorbance on the fluorescein graph was chosen that corresponded to a 
wavelength on the graph occurring before the peak wavelength. This absorbance needed to 
be less than 0.1 but preferably less than 0.05. The corresponding wavelength was recorded. 
The fluorescein emission spectrum was then taken for both the dye and the QD samples with 
the excitation wavelength set to the wavelength chosen from the absorption profile and a 1 
nm monochromator slit width. The wavelength to start collecting emission was set at a point 
about 10 nm greater than the excitation wavelength and the spectrum was taken. The area 
under the emission curve was calculated by integration and the following equation used to 
calculate the quantum yield: 
Φ  Φ	
  GradGrad	
 
nn	
  
Where ΦX is the fluorescence quantum yield of the QD sample, ΦST is the fluorescence 
quantum yield of the standard (fluorescein), Grad is the gradient of a plot of integrated 
fluorescence intensity versus absorbance of each sample, and n is the refractive index of each 
solvent.  The Grad values can be calculated from   ! "#  $  for both the sample and 
the standard, using the absorption value chosen before emission spectra were taken. 
PL QY values for the core CdSe nanocrystals were found to range from 13 – 48% in most 
syntheses we performed. For the ZnS overcoated QDs the values ranged from 7 – 35%, with 
lower values resulting when the overcoating process was flawed. 
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CHAPTER 4.  
LIGAND EXCHANGE METHODS 
4.0 Introduction 
The native hydrophobic surface ligands (e.g. TOP/TOPO/HDA) present a challenge when 
attempting to use quantum dots for single-molecule imaging in live cells, in vivo imaging, 
and other biological applications. This is because the surface ligands need to be changed or 
the whole QD has to be encapsulated to enable solubility in aqueous media and provide 
biocompatibility, while maintaining the desirable properties such as small size, high quantum 
yield, and pH stability. At the same time, biomolecules and receptors must be easily 
appended to the QD to facilitate sensing applications1, 2. For these reasons, surface 
modification plays an essential role as QDs are applied to biological systems. One of the 
advantages of compact hydrophilic QDs is that targeted studies can be carried out such as 
efficient FRET-based sensing with small QD to acceptor ratios and use in cellular uptake and 
imaging2-4. 
This chapter mainly focuses on methods used to displace the hydrophobic ligands using 
small hydrophilic organic molecules, some of which are derivatizable using general 
bioconjugation techniques. In Section 4.1, the most commonly used hydrophilic surface 
ligand in the literature (dihydrolipoic acid – DHLA) is discussed. Section 4.2 focuses on the 
synthesis, purification, and characterization of one modification to DHLA by appending a 
diamine molecule to the carboxylic end. An organophosphine derivative that is similar to 
trioctylphosphine (TOP) and that provides pH stability to QDs in acidic media is covered in 
 Section 4.3. Finally, various surfactants, amino acids, and amine
attempted as ligands in Section 4.4.
 
4.1 Dihydrolipoic Acid (DHLA)
Dihydrolipoic acid (DHLA) is a very stable
interactions of the two sulfur groups with the QD surface, but it is not very easily 
derivatizable. Water solubility of the QDs also depends on the ionization state of the 
carboxylic acid group, so DHLA capped quantu
aggregate in slightly acidic solutions
at least a year2. DHLA is formed by the reduction of the 1,2
(also called α-lipoic acid) using sodium borohydride (NaBH
 
Figure 4-1: DHLA formation by the r
 
DHLA was prepared by modifying procedures previously described
essential for successful reduction of the disulfide bond in thioctic acid. 
6 g of thioctic acid and 117 mL 
mixed in an Erlenmeyer flask
about 10 – 20 mg and the mixture stir
about four hours produced the best results. 
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 dithiol molecule because of the strong 
m dots are unstable and tend to slowly 
1, 2
. DHLA-capped QDs in basic media can be stable for 
-dithiolane ring of thioctic acid 
4) (Figure 4-1). 
eduction of thioctic acid using sodium borohydride in a sodium bicarbonate solution
2, 5
. Fresh
For the reduction step,
of a 0.25 M solution of sodium bicarbonate (
 in an ice bath. 2.8 g of NaBH4 was slowly added in aliquots of 
red for at least 1 hour. Allowing the reaction to stir for 
The solution changed from the bright
 
 
 chemicals were 
 
NaHCO3) were 
 yellow color 
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of thioctic acid to completely clear, indicating all the disulfide bonds had been broken. The 
DHLA was extracted by adding 100 mL of toluene, resulting in a two-phase solution. The 
bottom aqueous layer was acidified to pH 1 using concentrated HCl and the reduced thioctic 
acid (DHLA) transferred into the organic phase, resulting in a milky, white appearance. The 
phases were separated using a separatory funnel and the organic phase collected. Magnesium 
sulfate powder was added to remove any excess water from the organic phase, causing the 
solution to become clear, and was then filtered off with a Buchner funnel and vacuum. The 
solvent (toluene) was removed using a rotary evaporator (rotavap) at about 30 – 40°C. The 
pure DHLA was a clear, colorless, highly viscous liquid and was stored in a freezer. 
 
4.1.1 Ligand Exchange Procedure 
For effective ligand exchange to occur, the core/shell quantum dots needed to be dispersed in 
an excess of pure DHLA. QDs were precipitated out of solution using methanol, centrifuged, 
and the supernatant decanted. They were then air dried and weighed. DHLA was added to the 
dried QDs at a rate of about 2 mL DHLA per gram and stirred at 60 – 80°C for at least 2 – 3 
hours to displace the native hydrophobic shell (Figure 4-2). The solution was diluted with 4 
mL of dimethylformamide (DMF), which is a polar solvent that is miscible with water. The 
deprotonation of the terminal carboxyl group on DHLA is responsible for its stability in 
aqueous media2. Therefore an excess of the strong organic base, potassium tert-butoxide 
(K[t-BuO]) was slowly added while stirring until the QDs began precipitating out of solution. 
We found that about five times the initial mass of QDs was the best amount of K[t-BuO] 
needed for complete deprotonation of the terminal carboxyl group of DHLA. The solution 
was sedimented by centrifugation and the supernatant was discarded. The QDs were 
 redispersed in water and the acidity tested with pH paper
best stability. The water soluble QDs were purifi
DMF by centrifugation using 
volume of ultrapure water. A 0.45 
purification step, resulting in 
refrigerator and found to still be stable and fluorescent several months later. 
 
Figure 4-2: Schematic representation 
 
4.1.2 Characterization of DHLA
Water-soluble QDs were characterized by the same methods used for the core and shell 
overcoated QDs. Absorption and emissio
the photoluminescence quantum yield was calculated to be about 2.5 
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ed to remove excess K[t-BuO] and residual 
a centrifugal filter about five times and redispersed in a small 
µm disposable syringe filter was used as an additional 
a clear solution. These DHLA-capped QDs were stored in a 
 
 
of a layer of DHLA molecules on the outer surface of a quantum dot
-Capped Quantum Dots 
n spectra were obtained as before (Figure 4
– 14%, which was 
6
 
-3), and 
 lower than both the core and the overcoated QDs. This can be explained by the decreased 
passivation provided by DHLA as 
In neutral and basic media, the values remained around 10 
QY was found to be only about 2%. The absorption profile of the DHLA
same as that of the core/shell overcoated QDs, and both are red
compared to the CdSe core QDs.
 
Figure 4-3: Absorption and emission spectra of a DHLA
 
4.2 Amine-Terminated 
Thioctic acid can be covalently modified by carbodiimide coupling chemistry to create 
amine-terminated ligands that would potentially improve the solution properties of QDs by 
increasing the pH solubility range
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– 11%, while in acidic solutions, 
-capped QDs is the 
-shifted about 10 nm as 
 
-coated water-soluble QD sample compared to the core and 
core/shell absorption profiles 
Dihydrolipoic Acid  
1
. In this section, a large excess of 1,3-diaminopropane 
 
 (DAP) is appended to the carboxyl end of thioctic acid using a procedure modified from 
similar carbodiimide conjugations in the literature
 
Figure 4-4: Amine-
 
Briefly, 10 mol 1,3-diaminopropane 
nucleophilic catalyst – dimethylaminopyridine
dichloromethane (DCM) were 
minutes under N2 gas. The flask 
dicyclohexylcarbodiimide (DCC)
The reaction proceeded for 24 hours, stirring under 
formed in the solution. 
In this condensation reaction (depi
the carboxyl group on thioctic acid
acylisourea [3]. This intermediate reacted with the amine, DAP [4], to form the amine
terminated thioctic acid (TA/DAP) [5], which is an amide, and 
called N,N-dicyclohexylurea (DCU)
O-acylisourea can occur, with one resulting in the desired product. In the presence of exc
thioctic acid [1], an acid anhydride (
the DAP [4] to produce TA/DAP [5] and thioctic acid [1]. One undesired reaction pathway 
entails O-acylisourea [3] rearranging to form N
51 
1, 2, 7
 (Figure 4-4). 
 
terminated DHLA synthesized by carbodiimide coupling chemistry 
(DAP), 1 mol thioctic acid (TA), 0.2 mol 
 (DMAP), and 55 mol of the solvent 
mixed in an Erlenmeyer bulb and degassed for about 30 
was placed in an ice bath and 1.1 mol N,N-
 was dissolved in 5.5 mol of DCM and added 
N2 gas and a white, crystalline product 
cted in Figure 4-5), the carbodiimide, DCC [2], activated 
 [1], and produced the intermediate carboxylic ester, O
a white crystalline
 [6], which is removed by filtration. Side reactions of the 
α-lipoic anhydride) [7] may form, which then reacts with 
-acylurea [9], which is very stable. Using a 
 
of the 
drop wise. 
-
-
 precipitate 
ess 
 solvent such as dichloromethane (DCM) minimizes this side reaction because it has a low 
dielectric constant of 9.088 (i.e. a non
 
Figure 4-5: Carbodiimide coupling reactions for the formation of amine
 
Figure 4-6 shows 1H NMR spectra of TA/DAP 
synthesis, obtained with a Varian VXR
spectrometer. The multiplet peaks between 1.5 and 3.5 ppm in the thioctic acid spectrum can 
be seen in the TA/DAP spectrum as well. The DAP pea
apparent in the TA/DAP spectrum with the 2.5 ppm peeak shifted slightly to 2.7 ppm in the 
TA/DAP spectrum. 
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-polar solvent). 
-terminated thioctic acid
and some of the compounds used in the 
-300 nuclear magnetic resonance (NMR) 
ks at 1.5 and 2.5 ppm are also 
 
 
 Figure 4-6: 1H NMR spectra of TA/DAP and some of the compounds used
 
4.2.1 Purification of TA/DAP
4.2.1.1 Filtration 
The white crystalline product was 
vacuum pump 2 or 3 times and the crystals rinsed with extra DCM.
several days, crystals continued to form, so the solution was filtered approximately every two 
days. Cooling the solution did not seem to alter the rate of crystal formation at all. From 
NMR spectra (Figure 4-7) the slow crystallization product turned out to be mostly co
of the polyamine, diaminopropane (DAP).
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 for the synthesis
  
filtered out with a Buckner funnel, filter paper
 Over the course of 
 
 
 
, and 
mposed 
 Figure 4-7: 1H NMR spectra of DAP and the white crystalline precipitate recovered from reaction
 
Aliphatic amines (such as DAP) are reasonably strong bases bec
so they form water soluble salts that are insoluble in organic solvents when combined with 
acids9. This may be the explanation for the crystallization of the excess DAP.
NR
Lower ratios of DAP to TA were tried in an attempt to minimize the amount of time required 
for crystal formation. Ratios of 1 TA:3 or 5 DAP were tried, with the 1:5 ratio producing the 
best results because it appeared as though the 1:3 ratio reaction produ
products, probably following one of the undesirable reaction pathways mentioned earlier. 
Lowering the amount of DAP did not reduce the time needed for crystal formation, which 
ranged from 7 to 24 days regardless of the amount of DAP used
total mass of crystals expected from DAP, DCC, and DMAP, it was found that from 20 
76% these reactants did not crystallize out, but remained in solution, so extensive purification 
measures needed to be undertaken.
54 
ause of the alkyl substituents 
3 + HCOOH → [NHR3]+[HCOO]- 
ced some 
. From a calculation of the 
 
 
 
 
different 
– 
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4.2.1.2 Column Chromatography 
Whatman brand aluminum – backed, flexible thin layer chromatography (TLC) plates were 
spotted with TA/DAP, placed in a developing chamber with a 6% methanol to chloroform 
solvent ratio and ninhydrin (triketohydrindene hydrate C9H6O4) was used to detect the 
TA/DAP spots. Ninhydrin is useful for the detection of primary and secondary amines on 
TLC plates. It reacted with the free amines, evolving a deep blue/purple color called 
Ruhemann’s purple. Another color appeared above the purple (yellowish-orange) on the TLC 
plate indicating the presence of an iminium salt which results when a secondary amine is 
present. The TA/DAP sample was run through a chromatography column but chemically 
interacted with the silica gel and did not move through the column. 
 
4.2.1.3 Acetylation 
To prevent the TA/DAP from interacting with the silica column the amine groups were 
modified by acetylation using pyridine and acetic anhydride with DMAP as a catalyst. TLC 
was performed on the product with a 3% methanol in chloroform solution using iodine vapor 
and basic potassium permanganate (KMnO4) solution to stain the plates. KMnO4 was able to 
stain the tertiary amines produced by acetylation. A chromatography column was again used 
to purify the TA/DAP, with better results this time. The TA/DAP moved through the column, 
separated well, and a pure product was collected. The deacetylation of the TA/DAP was not 
possible because the sodium methoxide used would cleave both the acetyl and the amide 
bonds on the molecule. The use of sodium borohydride was attempted, but it was not strong 
enough to cleave the acetyl group, although it was able to reduce the disulfide bond. 
 Figure 4-8: 1H NMR spectra of acetylated TA/DAP compared to 
 
4.2.2 Reduction of Disulfide Bond
The same procedure used for reducing thioctic acid was followed to reduce TA/DAP. Instead 
of sodium bicarbonate, a 2:1 ratio of ethanol to water was used to dissolve the sample. 
Sodium borohydride (NaBH4
solution changed from yellow to clear when the disulfide bond of thioctic acid was broken. 
Leaving the solution stirring too long caused the disulfide bond to re
with acid at pH 1 or chloroform was used to extract the pure TA/DAP from aqueous solution, 
after an additional amount of water had been added to increase the polarity of the solution. 
Judging from the volumes of product recovered, it appeared as th
removed not only the TA/DAP very well, but also all the original reactants in solution. 
Yields of about 32 – 112% were realized, but impurities made up a portion of the product. 
NMR spectra of the reduced TA/DAP indicated that there may
unreduced TA/DAP in the sample (Figure 4
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the non-acetylated product
 
) was slowly added and the solution stirred for two hours. The 
-form. Either 
ough the extraction 
 have been both reduced and 
-9). 
 
 
toluene 
 Figure 4-9: 1H NMR spectra of reduced TA/DAP compared to the non
 
4.2.3 Ligand Exchange
Running the reduced TA/DAP t
and produced a clear solution. This solution was stirred with QDs overnight and remained 
very bright. After the addition of DMF, HCl was used to precipitate the QDs out of solution. 
Resuspension in water did not turn out well because many of the QDs fell out of solution, 
possibly indicating incomplete cap exchange or too many impurities in solution. The QDs 
however remained very bright.
 
4.3 Tris(3-hydroxypropyl)phosphine (THPP)
The quantum yield of QDs is diminished when thiols are used for ligand exchange because 
they do not electronically passivate the surface as well as organophosphines do
section, the organophosphine derivative, tris(hyd
is used for ligand exchange. The formula weight of THPP (208.24)
DHLA (208.343) so the same amounts were used to displace the native hydrophobic surface 
ligands. 
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-reduced product
 
hrough a syringe filter before use removed solid impurities 
 
 
roxypropyl)phosphine (THPP) (Figure 4
11
 is very similar to that of 
 
 
10
. In this 
-10) 
 Figure 4
 
QDs were combined with THPP and sonicated for 40 
viscous, the QDs did not disperse easily in such a small volume. The mixture was placed in 
an oil bath and stirred for 24 hours at 80°C under N
when illuminated by a UV lamp. Water wa
resulted. 
pH stability was tested  using hydrochloric acid and sodium hydroxide solutions. The initial 
pH was 8 and despite the addition of a large amount of acid, the solution acted as a buffer 
around pH 7. Continued addition of acid eventually dropped the pH to 2 and the QDs 
remained very stable and bright throughout. The addition of base changed the pH more 
rapidly, but the solution remained stable and bright. Although the solution started out with a 
yellow fluorescence color, after a few minutes, the basic sample changed to orange 
fluorescence. Over time, the QDs begun precipitating out of the basic solution and were no 
longer quite as bright. 
Absorption and emission spectra (Figures 4
neutral sample and both the acidic and basic samples. All three samples had peak absorptions 
at 555 nm, but the basic sample had a peak emission at 579 nm, unlike the other two samples 
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-10: Structure of tris(hydroxypropyl)phosphine (THPP) 
minutes. Since THPP was extremely 
2 gas. The QDs fluoresced very brightly 
s added to the mixture and a clear solution 
-11 and 4-12) were obtained for the original 
 at 568nm. The PL QY of the neutral THPP
of the acidic sample was 2.7%
 
Figure 4-11: Absorption spectra of THPP
 
Figure 4-12: Emission spectra of THPP
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-capped QDs was calculated to be 1.6%, and that 
 
-coated QDs in neutral, acidic, and basic solutions 
-coated QDs in neutral, acidic, and basic media, showing the red
solution 
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Wavelength (nm)
 
 
 
-shift of the basic 
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pH2
pH12
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Next, a mixture of DHLA and THPP was used for the ligand exchange procedure. 
Protonation of the DHLA carboxyl was achieved using K[t-BuO] and the QDs suspended 
readily in ultrapure water. pH testing indicated that the QDs were soluble in neutral and basic 
media, but not in acidic solution, although they remained bright. The absorption spectra for 
these samples are shown in Figure 4-13. No QD absorption onset peak could be seen for any 
of the samples. 
 
 
Figure 4-13: Absorption spectra of DHLA/THPP-coated QDs in neutral, acidic, and basic solutions 
 
4.4 Alternative Ligands 
Several hydrophilic organic molecules were studied as potential surface ligands for QDs. 
This section outlines the attempts made to displace the native hydrophobic surface cap with 
alternative ligands. 
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 4.4.1 α-lipoamide 
 
Due to its similarity to thioctic acid, 
for water solublization because it possesses a dithiol for binding to the QD surface and the 
amine functional group that could possibly provide solubility in acidic media. The procedure 
for reducing the disulfide bond to produce DHLA from thioctic acid was followed. 
lipoamide was not very soluble in sodium bicarbonate
solution. When NaBH4 was added and 
foam was slowly formed above the
using ultrapure water. The mixture was gradually acidified to pH 1 with hydrochloric acid 
and basified to pH 12 with sodium hydroxide. 
in all pH solutions from pH 1 to 12.
The process used for TA/DAP reduction with a 2:1 ratio of ethanol to water was attempted 
next. The α-lipoamide was partially soluble in
for four hours. The solution changed from yellow to white, indicating the disulfide bond had 
been broken.  The solution was diluted with water to increase its polarity and then 
chloroform was used for extraction
but after 24 hours, large round crystals formed.
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Figure 4-14: Structure of α-lipoamide 
α-lipoamide was deemed a potentially valuable ligand 
 and formed beads on top of 
the solution stirred for four hours, thick, insoluble 
 solution. Solubility tests were then done on
α-Lipoamide was found completely insoluble 
 
 the mixture, so NaBH4 was added and stirred 
. The reduced α-lipoamide was a clear, viscous solution 
 
α-
the 
 α-lipoamide 
 4.4.2 1,3-Diaminopropane
DAP was used in a manner similar to that for DHLA
and stirring at 60 – 80°C for 30 m
soluble by this method. 
 
4.4.3 DHLA and Diaminopropane
A 60:40 mole ratio of DHLA to 1,3
and 0.27 mL DAP. When mixed together, the mixture bec
heating. QDs were stirred in 
BuO] was used to deprotonate the DHLA carboxyl, but
was centrifuged and the supernatant discarde
seemed soluble. A centrifugal filter
out of the solution after centrifugation
surface. 
 
4.4.4 γ-aminobutyric acid
 
Solubility tests were performed on
attempt to use it for QD ligand exchange tests. 
N,N-dimethylformamide (DMF
62 
 (DAP) 
 ligand exchange by adding
inutes under N2 gas. The QDs were not found to be water 
 Mixture 
-diaminopropane (DAP) was prepared using 1
ame gel-like, but liquefied
this mixture overnight, and then 5 mL of DMF was 
 the solution began to solidify
d. The QDs were resuspended in water and 
 was used to purify the solution, but the QDs
, indicating the ligands were unstable on the 
 (GABA) 
 
Figure 4-15: Structure of γ-aminobutyric acid 
 the solid compound γ-aminobutyric acid (GABA)
It was found to be completely insoluble in 
), dimethyl sulfoxide (DMSO), hexane, butanol, acetone, and 
 it to QDs 
 mL DHLA 
 upon 
added. K[t-
, so it 
 precipitated 
QD 
 in an 
 chloroform. In toluene and ethanol, it was slightly soluble
water, 1,3-diaminopropane (DAP), and methanol. Si
methanol, these solvents could not be used to dissolve GABA for ligand exchange.
 
4.4.5 Surfactant Encapsulation
The hydrophobic interiors of surfactant micelles are capable of holding hydrophobic 
quantum dots12-16. In this study, a cat
(CTAB) and an anionic detergent, lauryl sulfate (sodium dodecyl sulfate or SDS) were used 
to encapsulate hydrophobic QDs (Figure 4
molecules was chosen based on litera
Figure 4-16: 
 
A concentrated QD solution was prepared using a ratio of 1 mL of chloroform to 0.1 g of 
pre-dried, pre-weighed QDs. The surfactants were dissolved in water to a concentration 
slightly below each of their critical micelle concentration (CMC) values of 
CTAB17 and 0.0083 M for SDS
solutions were added drop wise in an attempt to form an oil
SDS, the QD solution dissolved readily but produced a milky appearance, however, in 
CTAB, the QD solution was completely insoluble and sank to the bottom of the flask 
initially. After more stirring, it dispersed a little, but not completely. Each solution stirred for 
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 and was completely 
nce QDs are insoluble in water and 
 
ionic detergent, cetyltrimethylammonium bromide 
-16). A mole ratio of 1 QD:300 surfactant 
ture values14. 
 
 
Structures of the surfactants SDS (top) and CTAB (bottom) 
0.009
18
. With the surfactant solutions vigorously stirring, the QD 
-in-water micro-emulsion. In 
soluble in 
 
2 M for 
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5 – 10 minutes, but no micro-emulsion formed since the solutions did not become clear and 
the QDs stuck to the stir bars and sides of the flasks. Chloroform was slowly evaporated 
while stirring and heating to 65°C, therefore transferring the QDs into the aqueous phase. 
The solutions were poured into vials, where some precipitation was immediately observed. 
Both the solutions and the precipitates were very fluorescent. Absorption and emission 
spectra were taken of the solutions. The emission spectrum closely resembled that of the 
original QDs with a slight red-shift (Figure 4-18). 
 
 
Figure 4-17: Absorption and emission spectra of an SDS-encapsulated water-soluble QD sample 
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Figure 4-18: Emission spectrum of a CTAB-encapsulated water-soluble QD sample compared to that of the TOP/TOPO 
covered core/shell QD sample 
 
The pH stability of the encapsulated QDs was tested using HCl and NaOH (initial pH was 7). 
The pH of SDS-covered QDs dropped fast with the addition of acid, and the QDs begun to 
become insoluble around a pH of 3, although still remaining fairly fluorescent. By pH 1 they 
were barely fluorescent anymore. The pH of CTAB-covered QDs took longer to reduce, but 
the fluorescence faded faster. By pH 3 they were barely fluorescent at all. When base was 
added, the SDS-covered QDs were still soluble and very bright at pH 12. The CTAB-covered 
QDs were still bright but some QDs precipitated out by pH 12. Both solutions remained 
bright and seemed more stable in basic pH than acidic solutions. 
 
4.4.6 Amino Acid Modification of Thioctic Acid 
The procedure for TA/DAP synthesis in Section 4.2 was followed using 5 mol each of L-
Lysine and L-Glutamine (Figure 4–19) instead of diaminopropane. Neither amino acid was 
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 soluble in DCM so the reactions were unable to proceed as usual. An aqueous system is the 
only way for this reaction to proceed, so carbodiimide coupling using 1
dimethylaminopropyl) carbodiimide hydrochloride (EDC) in
hydroxysuccinimide (NHS) may be used to produce amino acid modified DHLA.
 
Figure 4-19: Structures of the amino acids L
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CHAPTER 5.  
EMBEDDING QUANTUM DOTS IN POLYMER MICROSPHERES 
5.0 Introduction 
Encapsulating quantum dots in polymer shells is a good way to functionalize their surfaces 
and manipulate their solution properties. By embedding QDs in polymer microspheres, their 
unique optical properties such as simultaneous excitation and size-tunable emission can be 
utilized for applications such as multiplexing1 and controlled drug delivery2-5. 
Some of the encapsulation methods described in this chapter were complicated by 
aggregation of the microspheres and low QD uptake. Section 5.1 illustrates the results of 
embedding QDs by swelling polystyrene beads. An oil-oil emulsion technique is employed in 
Section 5.2 for encapsulating QDs in polymer microspheres. Finally, a four-stream vortex 
mixer is used to create microspheres with a smaller size distribution and higher fluorescence 
intensity. 
 
5.1 QD–Tagged Carboxyl–Terminated Polystyrene Beads 
In microfluidic systems, measurements of flow fields have been traditionally done with 
fluorescent dye-tagged polymer microspheres using particle image velocimetry (PIV). PIV is 
the method used to optically measure properties of a fluid such as the velocity6, 7. The use of 
quantum dots instead of dyes in this type of system is advantageous because of the superior 
properties QDs possess. 
The following procedure was used to suspend the carboxyl-terminated polystyrene beads in 
an organic solvent so that quantum dots could be embedded in them. One drop of 2 µm 
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polystyrene beads in water was placed in a small Eppendorf tube, ultrapure water (resistivity 
> 18 MΩ cm) was added, and the solution mixed with a vortex mixer. The mixture was then 
centrifuged at a rate of 4500 rpm for 5 minutes. This caused aggregates to form, so 2500 rpm 
for 3 minutes was used instead. The water was decanted and ethanol added to the polystyrene 
beads. The solution was mixed again with the vortex mixer, centrifuged, and decanted. 
Butanol was added next and the above procedure was repeated. A 5% chloroform in butanol 
solution was prepared and added to the polystyrene beads and was left for 30 minutes to 
enable the beads to swell. 
15 µL of a highly concentrated solution of QDs in toluene was added to the swelled beads, 
vortexed and left for an hour to allow the QDs to diffuse into the beads. The solution was 
mixed again with the vortex mixer, placed in a sonic bath for a few minutes, centrifuged, and 
the supernatant decanted. Butanol was added to rinse the beads and the solution was mixed 
again, centrifuged and, decanted. Finally the solution was resuspended in butanol and stored 
in a refrigerator. 
The QD-tagged polystyrene beads were used for PIV. However, due to the low uptake of 
QDs by the polystyrene during the swelling procedure, no fluorescence could be observed in 
the PIV system. 
 
5.2 Double-Emulsion Solid-Oil-Oil Microsphere Fabrication 
Bioerodible polyanhydrides have been shown to be useful for drug delivery applications2-5. 
The anhydride monomers 1,6-bis(p-carboxyphenoxy)hexane (CPH) and sebacic acid (SA) in 
Figure 5-1 are used to form poly(CPH) and poly(SA) respectively. Drug distribution studies 
 using poly(SA) showed that the more hydroph
throughout the microspheres and the smaller sized spheres exhibited the best distribution
Figure 5-1: Chemical structures of poly(CPH) (left) and poly(SA) (right)
 
Using previously established methods for encapsulating and stabilizing proteins and drugs
8-10
, quantum dots were embedded in polyanhydride microspheres with the assistance of 
members of the Narasimhan Research Group from the Department of Chemical and 
Biological Engineering at Iowa State University.
 
5.2.1 Frozen Heptane Pr
In this method, the first emulsion consisted of 100 mg poly(SA) and 6 mg core
covered in TOP/TOPO, dissolved in 3 mL methylene chloride. A homogenizer was used to 
agitate the solution at 30,000 rpm for one minute, then 3 mL par
chloride were added while the homogenizer was running but turned down to 10,000 rpm, 
forming the second emulsion. The homogenizer rate was raised to 20,000 rpm for one more 
minute, and then the emulsion was added drop wise to a
containing 200 mL heptane and stirred for two hours. The microspheres were filtered out of 
the solution and dried in a vacuum oven.
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The shapes and sizes of the microspheres were determined using a JEOL 840A scanning 
electron microscope (SEM). From the SEM images, it was apparent that the microspheres 
had formed large aggregates and the desired monodisperse size distribution was not achieved 
(Figures 5-2 and 5-3). 
 
  
  
Figure 5-2: SEM images of aggregated polyanhydride microspheres fabricated by frozen heptane method 
 
500X 1500X 
50X 150X 
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Figure 5-3: SEM images showing individual polyanhydride microspheres within an aggregate 
 
5.2.2 Petroleum Ether Precipitation Method 
In this method 16.3 mg of dried CdSe/ZnS QDs were dissolved in 13.6 mL of 
dichloromethane (DCM) and sonicated, resulting in a QD concentration of 1.2 mg/mL. 145 
mg of poly(CPH) was weighed out into a 50 mL centrifuge tube and 5 mL DCM added to 
make a 30 mg/mL solution. The centrifuge tube was mixed with a vortex mixer to dissolve 
the polymer and 5 mL of the QD solution was added. The polymer and QD mixture was 
poured into a 400 mL bath of petroleum ether (80:1 ratio of non-solvent to solvent) and 
precipitation occurred. The precipitate was filtered using a 90 cm Buchner funnel set up on a 
2 L filter flask with a vacuum and Whatman No. 2 filter paper. When dry, the microspheres 
15000X 50000X 
5000X 
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were scraped off the filter paper onto a weigh boat and dried in a vacuum oven overnight. 
The microspheres were then transferred to a micro-centrifuge tube, weighed and stored in a 
desiccator in a cooler. The petroleum ether that was used for precipitation was checked for 
fluorescence using an Horiba Jobin Yvon Fluoromax®-4 spectrofluorometer. No fluorescence 
was observed, indicating that all the QDs had been taken up into the microspheres. 
The whole procedure was repeated using poly(SA) but the poly(SA) microspheres were not 
as bright as the poly(CPH) ones when illuminated with an ultraviolet lamp. 
 
  
  
Figure 5-4: SEM images of QD-embedded poly(CPH) microspheres 
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SEM images of the two microsphere samples indicated that some aggregates formed but the 
individual microspheres were distinguishable (Figures 5-4 and 5-5). More SEM images of 
the microspheres can be found in Appendix II. 
 
  
  
Figure 5-5: SEM images of QD-embedded poly(SA) microspheres 
 
Poly(SA) was again used for the precipitation procedure but instead of TOP/TOPO capped 
QDs, inactivated DHLA capped QDs were used. To prepare these, the QDs were precipitated 
out of solution using methanol and air dried. DHLA was added to the QDs, the solution 
agitated for 45 minutes using a sonic bath,  and then stirred at 78°C for 24 hours in an N2(g) 
atmosphere. This QD solution was used for the petroleum ether precipitation method 
76 
 
previously described. The microspheres fluoresced when illuminated by an ultraviolet lamp. 
The SEM images in Figure 5-6 demonstrate some aggregation of the microspheres. More 
images can be found in Appendix II. 
 
  
Figure 5-6: SEM images of inactivated DHLA-capped QD-embedded poly(SA) microspheres 
 
Total internal reflection fluorescence (TIRF) microscopy was used to image the region of a 
sample of the microspheres that was closest to the glass surface of the slide. TIRF uses an 
evanescent wave to excite and illuminate quantum dots in that region. Samples of QD-tagged 
microspheres were prepared. The first was a dry microsphere sample; the second was 
dispersed in water; and the third was dispersed in methanol. A final sample consisted of 
microspheres with TOP/TOPO QDs embedded in them.  Video images of fluorescence from 
QDs in each sample were recorded with a digital camera and screenshots of these videos are 
presented in Figure 5-7. 
 
1500X 150X 
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Figure 5-7: TIRF images of fluorescence from DHLA-capped QDs embedded in microspheres in (a) a dry sample, (b) 
water, and (c) methanol. Image (d) is a sample of TOP/TOPO QDs in microspheres. 
 
5.3 Diblock Copolymer QD Encapsulation 
One disadvantage of the precipitation methods described in section 5.2 is that the mixing is 
not intense enough, so the microsphere sizes tend to be relatively large (about 200 nm). 
Using higher energy impingement mixing, it is possible to minimize mass transfer limitations 
and produce smaller particles11. In this process, a stream of polymer, QDs, and solvent is 
forced towards three streams of water at a high velocity. A precipitate is formed rapidly when 
the different streams meet and fine particles result. The following investigations were 
(a) (b) 
(c) (d) 
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conducted with collaborators in the Department of Chemical Engineering and Materials 
Science at the University of Minnesota. 
Dry QD samples were dissolved in tetrahydrofuran (THF) to make 10 mg/mL solutions. 
From each solution, 2 mL were measured out, mixed with 50 mg of either poly(lactic-co-
glycolic acid) (PLGA)-polyethylene glycol (PEG) copolymer or polystyrene(9.5K)-
polyethylene glycol(5K) copolymer (PS-PEG). To this, 3 mL THF was added, and placed in 
a 5 mL syringe. Two 45 mL syringes and one other 5 mL syringe were filled with water, 
bringing the total volume of the system to 100 mL. Two syringe pumps were used to force 
the contents of the syringes into the four stream vortex mixer with the speed ratio between 
the 5 mL and 45 mL syringes being 1:9. 
All the samples showed fluorescence when illuminated by an ultraviolet lamp indicating the 
QDs were encapsulated within the polymer spheres. The mass and intensity averaged 
diameters were obtained by dynamic light scattering (DLS) analysis, and scanning electron 
microscopy (SEM) was used to image the shapes of the particles. 
 
  
Figure 5-8: Intensity (left) and mass (right) particle size distributions by DLS of 508 nm emitting QD polymer spheres 
made by turbulent mixing with PLGA-PEG copolymer 
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Figures 5-8 to 5-10 show the DLS results of the PGLA-PEG system using 508 and 608 nm 
emitting QDs. 
[dI and dm represent intensity average diameter and mass average diameter respectively] 
 
  
Figure 5-9: Intensity (left) and mass (right) particle size distributions by DLS of unsonicated 508 nm emitting QD polymer 
spheres made by turbulent mixing with PLGA-PEG copolymer 
 
  
Figure 5-10: Intensity (left) and mass (right) particle size distributions by DLS of 608 nm emitting QD polymer spheres 
made by turbulent mixing with PLGA-PEG copolymer 
 
Figures 5-11 to 5-13 show SEM images and mass average diameter DLS data of PS-PEG 
encapsulated QDs emitting at 506, 546, and 611 nm. Supplementary SEM images for each 
sample can be found in Appendix II. 
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Figure 5-11: SEM image and mass particle size distribution by DLS of 506 nm emitting QD polymer spheres made by 
turbulent mixing with PS-PEG copolymer 
 
   
Figure 5-12: SEM image and mass particle size distribution by DLS of 546 nm emitting QD polymer spheres made by 
turbulent mixing with PS-PEG copolymer 
 
   
Figure 5-13: SEM image and mass particle size distribution by DLS of 611 nm emitting QD polymer spheres made by 
turbulent mixing with PS-PEG copolymer 
dm = 167 nm 
dm = 285 nm 
dm = 235 nm 
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The QD-tagged polymer spheres were used for particle image velocimetry (PIV). The 
apparatus included a LaVision cooled charge-coupled device (CCD) high speed 12bit camera 
and a pulsed 532 nm emitting Nd:YAG (neodymium-doped yttrium aluminum garnet) laser. 
The QD-tagged polymer spheres each produced an intensity of 70 – 80 counts per pixel and 
the background was about 40 counts per pixel (Figure 5-14). In comparison, when the same 
system was run using commercially produced 1 µm polystyrene tagged with fluorescein 
isothiocyanate (FITC) dye, an intensity of 100 counts per pixel was recorded. 
 
  
Figure 5-14: 12-bit camera image of QD-tagged polystyrene beads illuminated by a pulsed laser 
 
82 
 
5.4 References 
1. Han, M.; Gao, X.; Su, J. Z.; Nie, S., Quantum-dot-tagged microbeads for multiplexed 
optical coding of biomolecules. Nature Biotech. 2001, 19, (7), 631-635. 
2. Kipper, M. J.; Shen, E.; Determan, A.; Narasimhan, B., Design of an injectable 
system based on bioerodible polyanhydride microspheres for sustained drug delivery. 
Biomaterials 2002, 23, (22), 4405-12. 
3. Berkland, C.; Kipper, M. J.; Narasimhan, B.; Kim, K. K.; Pack, D. W., Microsphere 
size, precipitation kinetics and drug distribution control drug release from biodegradable 
polyanhydride microspheres. J Control Release 2004, 94, (1), 129-41. 
4. Determan, A. S.; Trewyn, B. G.; Lin, V. S.; Nilsen-Hamilton, M.; Narasimhan, B., 
Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres. J 
Control Release 2004, 100, (1), 97-109. 
5. Kipper, M. J.; Wilson, J. H.; Wannemuehler, M. J.; Narasimhan, B., Single dose 
vaccine based on biodegradable polyanhydride microspheres can modulate immune response 
mechanism. J Biomed Mater Res A 2006, 76, (4), 798-810. 
6. Santiago, J. G., Wereley, S. T., Meinhart, C. D., Beebe, D. J., Adrian, R. J., A particle 
image velocimetry system for microfluidics. Experiments in Fluids 1998, 25, (4), 316-319. 
7. Prasad, A. K., Stereoscopic particle image velocimetry. Experiments in Fluids 2000, 
29, (2), 103-116. 
8. Determan, A. S., Jennifer H. Wilson, Matt J. Kipper, Michael J. Wannemuehler, 
Balaji Narasimhan, Protein stability in the presence of polymer degradation products: 
Consequences for controlled release formulations. Biomaterials 2006, 27, (17), 3312-3320. 
83 
 
9. Torres, M. P.; Determan, A. S.; Anderson, G. L.; Mallapragada, S. K.; Narasimhan, 
B., Amphiphilic polyanhydrides for protein stabilization and release. Biomaterials 2007, 28, 
(1), 108-16. 
10. Determan, A. S.; Graham, J. R.; Pfeiffer, K. A.; Narasimhan, B., The role of 
microsphere fabrication methods on the stability and release kinetics of ovalbumin 
encapsulated in polyanhydride microspheres. J Microencapsul 2006, 23, (8), 832-43. 
11. Zhu, Z.; Anacker, J. L.; Ji, S.; Hoye, T. R.; Macosko, C. W.; Prud'homme, R. K., 
Formation of Block Copolymer-Protected Nanoparticles via Reactive Impingement Mixing. 
Langmuir 2007, 23, (21), 10499-10504. 
 
84 
 
CHAPTER 6.  
FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) 
6.0 Introduction 
FRET investigations between two different engineered proteins and quantum dots are 
covered in this chapter. The results indicate that FRET indeed occurs between the QDs and 
Cy3 dyes on the protein molecules. It is also shown that there is an increase in the 
fluorescence intensity in each sample when only unlabeled protein molecules are placed on 
the surface of the quantum dots. 
 
6.1 FRET with Quantum Dots and Proteins 
In fluorescence resonance energy transfer (FRET), energy is nonradiatively transferred from 
a donor to an acceptor fluorophore which are relatively close together 1. Dipole-dipole 
interactions between the two fluorophores are the driving force of FRET and these 
interactions depend heavily on the distance of separation between them1, 2. Quantum dots 
have been shown to be useful as donors for FRET with dyes acting as the acceptor 
fluorophores. Multiple dyes can be placed on the surface of the quantum dots to increase the 
FRET rate since small changes in the distance between the two fluorophores cause a large 
change in the FRET intensity2-6. 
Appending a polyhistidine tag onto an engineered protein labeled with a dye molecule 
enables the protein to self-assemble on the quantum dot surface via metal affinity interactions 
between the histidine tag and the shell of the QD1, 2, 7, 8. The following Sections discuss 
FRET studies carried out between CdSe/ZnS core-shell quantum dots and engineered 
 proteins provided by the department of Biochemistry, Biophysics, and Molecular Biology at 
Iowa State University. 
 
Figure 6-1: 
6.1.1 FRET with Modified Influenza Haemagglutini
Membrane glycoproteins are the components of viruses that mediate the fusion of viral a
cellular membranes for the transfer of viral genetic material into the cell. The influenza virus 
haemagglutinin (HA) is one of the best characterized membrane glycoprotein
13.5 nm in length, is composed of three identical subunits, with e
glycopolypeptides connected by a disulfide bond. The glycopolypeptides are HA
328 residues, and HA2, with 221 residues. The carboxyl terminus of HA
viral membrane9. 
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Schematic representation of a protein-covered quantum dot 
 
n 
ach one made up of two 
2 secures it to the 
nd 
s. HA, which is 
1, which has 
86 
 
 
Figure 6-2: Structure of influenza haemagglutinin10 
 
Samples of engineered influenza virus haemagglutinin (HA) with polyhistidine tags and 
known concentrations were obtained. One sample of protein was labeled with Cy3 dye and 
the other was not. The total number of protein molecules conjugated onto each QD was kept 
the same but the ratio of the QD to Cy3-labeled protein was varied. Hence, each QD had 
some labeled and some unlabeled protein molecules attached to it. The number of moles of 
QD chosen was 30 picomoles and the molar ratio of QD to protein was used to calculate the 
volume of each needed. Core-shell CdSe/ZnS quantum dots capped with DHLA were used 
for the FRET investigations. 
A small amount (about 50 µL) of 10 mM sodium tetraborate buffer (borax) at pH 8 was 
pipetted into several small Eppendorf tubes. Labeled and unlabeled protein were added to the 
buffer and shaken to ensure neither one preferentially bound to the QDs, which were then 
added to the solutions and allowed to coordinate with the protein molecules at room 
temperature for one hour. Each Eppendorf tube was topped off with borate buffer to the 
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predetermined total volume which was either 1 – 1.5 mL when using large quartz cuvettes or 
0.25 mL for small ones. In subsequent runs, citrate-phosphate buffer (at pH 5 and 7) and 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffer were used instead of 
borax. 
After an hour, fluorescence spectra were obtained using quartz cuvettes, five monochromator 
slits, and an excitation wavelength of 390 nm on an Horiba Jobin Yvon Fluoromax®-4 
spectrofluorometer. Two controls were run, one with QDs in buffer without any protein, 
using a 390 nm excitation, and the other with protein in buffer only, using a 500 nm 
excitation. For the latter control, no appreciable peak could be observed for the Cy3 dye 
when excited at 390 nm as is apparent in Figure 6-3.  
 
  
Figure 6-3: Fluorescence spectra of Cy3 dye-labeled protein excited at 390 nm (left) and at 500 nm (right) 
 
The rest of the samples contained varying ratios of QD to protein and were excited at 390 
nm. Figure 6-4 contains data from FRET experiments using 1, 2, 3, 4, and 8 labeled protein 
molecules on QD, with the rest of the proteins being unlabeled up to eight total protein 
molecules. Borate buffer at pH 8 was used with a total volume of 0.25 mL in each sample. 
This volume was found to be too small for the large quartz cuvettes. Since so few protein 
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molecules had dye on them, the Cy3 peak is barely visible (around 564 nm) to the right of the 
large QD peak at 527 nm. 
 
 
Figure 6-4: Influenza haemagglutinin (HA) on QDs in borate buffer with 8 total protein molecules 
 
The total volume of borate buffer was raised to 1 mL and the ratios of protein to QD were 
changed until a total of twelve Cy3-labeled protein molecules were placed on the QDs. A 
slightly more pronounced Cy3 peak was then produced (Figure 6-5). It can also be noted that 
the QD peak diminishes greatly in intensity when either 8 Cy3 dyes (Figure 6-4) or 12 Cy3 
dyes (Figure 6-5) are present, indicating the successful transfer of energy by FRET from the 
QD donor to the Cy3 dye acceptor. The number of dyes present also obviously affects the 
FRET intensity.  
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Figure 6-5: Influenza haemagglutinin (HA) on QDs in borate buffer with 12 total protein molecules 
 
When the buffer was changed from borax to HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid), the intensity of the Cy3 fluorescence increased slightly 
(Figure 6-6). 
 
 
Figure 6-6: Influenza haemagglutinin (HA) on QDs in HEPES buffer with 12 total protein molecules 
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The use of citrate-phosphate buffer increased the Cy3 fluorescence relative to the QD 
fluorescence still further as seen in Figures 6-7 and 6-8, with the pH of the buffer having no 
perceivable effect on the system when it was changed from pH 5 to 7. 
 
 
Figure 6-7: Influenza haemagglutinin (HA) on QDs in pH 5 Citrate-Phosphate buffer with 12 total protein molecules 
 
 
Figure 6-8: Influenza haemagglutinin (HA) on QDs in pH 7 Citrate-Phosphate buffer with 12 total protein molecules 
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It is also important to note that in each case presented, the QDs covered with unlabeled 
protein molecules have a higher fluorescence intensity than the QDs without any protein at 
all (i.e. the QD control), indicating that the layer of protein on the surface positively 
influences the emission of quantum dots. 
 
6.1.2 FRET with Modified SNARE Complex 
SNARE proteins are membrane proteins that play an important role in the fusion of synaptic 
vesicles with the plasma membrane in eukaryotic cells. The proteins form a ternary complex 
with four parallel α-helices called a SNARE complex. The components of the α-helix bundle 
include one helix of syntaxin 1a and two helices of synaptosome-associated protein of 25 
kDa (SNAP-25), which are plasma membrane proteins. The last helix of synaptobrevin 2 
(also called vesicle-associated membrane protein 2 – VAMP 2), which is a synaptic vesicle 
protein, completes the bundle11-14. 
 
Figure 6-9: Structure of a SNARE complex consisting of syntaxin 1a, SNAP 25, and VAMP 2 
  
 Several protein samples with differences in the SNARE complex were provided by the 
department of Biochemistry, Biophysics, and Molecular Biology at Iowa State University
Each protein was engineered with a histidine
samples were prepared. To prevent the protein molecules from sticking to each other, one 
end was encapsulated in a 100 nm liposome bilayer vesicle, with the histidine
on the outside to facilitate conjugation onto QDs (Figure 6
engineered included one with only a syntaxin 1a 
consisting of a syntaxin 1a α-
syntaxin 1a, SNAP 25, and a VAMP 2 helix.
 
Figure 6-10: Schematic representation of the modified SNARE complex attached to a quantum dot
 
FRET investigations were carried out with each complex separately using the same 
procedure as that used for the influenza haemagglutinin (HA) previously discussed. Small 
quartz cuvettes were filled with 0.25 mL of the sample solutions and fluorescence spec
obtained. From Figures 6-11 to 6
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intensity, especially in the binary and ternary systems. After further investigations, we 
concluded that the liposome vesicle attached to the protein molecules was too large and 
hindered the conjugation of protein molecules to quantum dots, thus limiting the number of 
protein molecules on each QD and interfering with the FRET mechanism. For future 
analyses, the liposome vesicle would need to be much smaller so that enough proteins could 
conjugate onto the QDs. 
 
 
Figure 6-11: Single SNARE complex on QDs in HEPES buffer with 12 total protein molecules 
 
The viability of using HEPES buffer as a solvent for FRET investigations was studied by 
testing the solubility of QDs in it. 3 µL of DHLA-covered water soluble QDs were dropped 
out of solution using a centrifugal filter and centrifuging at 2500 rpm for 3 minutes. The 
water was decanted and 6 µL of HEPES buffer added to resuspend the QDs. The solution 
was found to be homogenous, indicating that QDs are very soluble in HEPES buffer. 
See Appendix III for more FRET fluorescence spectra using the SNARE complex system. 
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Figure 6-12: Binary SNARE complex on QDs in HEPES buffer with 12 total protein molecules 
 
 
Figure 6-13: Ternary SNARE complex on QDs in HEPES buffer with 12 total protein molecules 
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CHAPTER 7.  
CONCLUSIONS AND FUTURE WORK 
7.1 Conclusions 
The overall objective of the research presented in this thesis was to preserve the valuable 
properties of semiconductor nanocrystal quantum dots, while changing their solution 
properties to render them useful for biological applications. This was achieved by modifying 
their surfaces via ligand exchange and encapsulation techniques.  
Chapter 4 mainly focused on methods used to displace hydrophobic surface ligands using 
small hydrophilic organic molecules, such as dihydrolipoic acid (DHLA) and 
tris(hydroxypropyl)phosphine (THPP), and derivatization of some these molecules by 
carbodiimide bioconjugation techniques. Several quantum dot encapsulation methods in 
polymer shells to functionalize their surfaces and manipulate their solution properties were 
covered in Chapter 5. The most promising method involved using a four-stream vortex mixer 
to create quantum dot-embedded polymer microspheres with a small size distribution and 
high fluorescence intensity. The ability of polyhistidine tags to self assemble onto QDs via 
metal coordinating interactions was exploited in Chapter 6 by using dye-labeled proteins to 
perform fluorescence resonance energy transfer (FRET) investigations between two different 
engineered proteins as acceptor fluorophores and quantum dots as FRET donors. FRET can 
be applied to deriving the structure of complex molecules by measuring the distances 
between amino acids and detecting enzymatic activity in cells by sensing the changes in the 
FRET signal when an enzyme attacks the substrate attached to the QD. 
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A common theme between the embedding and ligand exchange methods is that they both 
attempt to enhance the passivation of the QD surface, therefore increasing the brightness of 
the photoluminescence emitted. In addition to this, the stability of the whole system is of 
utmost importance because QDs need to be robust in order to function properly in biological 
systems. The surface modification should also augment the compatibility of the QD with its 
surroundings, such as inside the cytoplasm or endosome of a cell, to avoid problems like 
aggregation. Finally, the ease of cytoplasmic or endosomal uptake and the pH stability of the 
surface modification system determine whether or not it will be useful in the systems desired. 
 
7.2 Future Work 
Many of the organic molecules used for ligand exchange in Chapter 4 are capable of being 
developed further to produce stable, robust, bright, and biocompatible quantum dots with 
high photoluminescence quantum yields (PL QY). Increased multifunctionality is also 
potentially achievable by combining two or more of the organic molecules on the same QD 
surface such as DHLA with TA/DAP and/or THPP. Hence, nanocrystals can be produced 
that are stable over a broad pH range. 
Bioconjugation techniques such as the carbodiimide coupling chemistry employed in the 
synthesis of amine-modified thioctic acid (TA/DAP) can be enhanced using a water soluble 
carbodiimide, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) in 
combination with N-hydroxysuccinimide (NHS), instead of N,N-dicyclohexylcarbodiimide 
(DCC). Consequently, different molecules can be successfully appended to the carboxyl 
group on DHLA. Some molecules that could benefit from this aqueous conjugation include 
amino acids and carbohydrates. 
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Further exploration into stable surfactant molecule micelles within which QDs can be 
encapsulated is needed. The natural amphiphilic nature of these molecules makes them 
potentially valuable as QD surface coating agents. Finally, phosphine derivatives, such as 
tris(hydroxypropyl) phosphine (THPP), can be investigated further because they may be able 
to provide more of the elusive electronic passivation needed by QDs to keep the PL QY high. 
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APPENDIX I 
SUPPLEMENTARY TEM IMAGES OF QUANTUM DOTS 
Lattice fringes and an approximately monodisperse size distribution (about 6 nm) can be seen 
in TEM images of CdSe/ZnS core/shell nanocrystals taken with a 2007 JEOL 2100 200 kV 
scanning and transmission electron microscope (STEM) at the Ames Laboratory at Iowa 
State University (Figures I-1 and I-2).  
 
   
Figure I-1: Electron diffraction patterns of colloidally prepared CdSe/ZnS core-shell nanocrystals  
 
     
Figure I-2: TEM images of colloidally prepared CdSe/ZnS core-shell nanocrystals 
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Figure I-2: Continued
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APPENDIX II 
SUPPLEMENTARY SEM IMAGES OF POLYMER MICROSPHERES 
The poly(CPH) and poly(SA) microspheres used to encapsulate TOP/TOPO-capped QDs 
formed differently sized aggregates seen in Figures II-1 to 3. SEM images were obtained 
using a JEOL 840A scanning electron microscope. 
 
  
  
Figure II-1: SEM images of QD embedded poly(CPH) microspheres (sample 1) 
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Figure II-2: SEM images of QD embedded poly(CPH) microspheres (sample 2) 
 
  
Figure II-3: SEM images of QD embedded poly(SA) microspheres 
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The poly(SA) microspheres used to encapsulate inactivated DHLA-capped QDs formed 
differently sized aggregates seen in Figures II-4. 
   
   
   
   
Figure II-4: SEM images of inactivated DHLA-capped QD embedded poly(SA) microspheres 
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QD encapsulated PS-PEG copolymer spheres made by turbulent mixing were imaged by 
scanning electron microscopy. The supplementary SEM images are presented below in 
Figures II-5 to II-7. 
 
   
Figure II-5: SEM images 506 nm emitting QD polymer spheres made by turbulent mixing with PS-PEG copolymer 
 
  
   
Figure II-6: SEM images 546 nm emitting QD polymer spheres made by turbulent mixing with PS-PEG copolymer 
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Figure II-7: SEM images 611 nm emitting QD polymer spheres made by turbulent mixing with PS-PEG copolymer 
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APPENDIX III 
SUPPLEMENTARY FRET FLUORESCENCE SPECTRA 
FRET investigations with three SNARE complexes and four protein molecules per QD. 
Fluorescence spectra were obtained on an Horiba Jobin Yvon Fluoromax®-4 
spectrofluorometer with an excitation wavelength of 390 nm. 
 
 
Figure III-1: Single SNARE complex on QDs in HEPES buffer with 4 total protein molecules 
 
 
Figure III-2: Binary SNARE complex on QDs in HEPES buffer with 4 total protein molecules 
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Figure III-3: Ternary SNARE complex on QDs in HEPES buffer with 4 total protein molecules 
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